Actinic Keratosis
Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation
Christopher Nelson, MD, University of South Florida, Tampa, Florida; Darrell Rigel, MD, New York University Medical Center, New York, New York
Topical Imiquimod Therapy for Actinic Keratosis Is Long-Term Clearance a Realistic Benefit?
by James Q. Del Rosso, DO, FAOCD Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and Associate Professor (Dermatology), Touro University College of Osteopathic Medicine, Henderson, Nevada.
The Use of Photodynamic Therapy in the Treatment of Actinic Keratoses and in Photorejuvenation
Therapeutic and Aesthetic Uses of Photodynamic Therapy Part one of a five-part series by Michael H. Gold, MD Medical Director, Gold Skin Care Center and The Laser & Rejuvenation Center, Nashville, Tennessee Abstract The utilization of aminolevulinic acid–photodynamic therapy in dermatology has steadily been on the rise since its introduction into our therapeutic armamentarium almost [...]
fred klumpp |&co
Considerations for Use of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratosis in Elderly Patients
by William Philip Werschler, MD, FAAD, FAACS Department of Medicine/Dermatology, University of Washington School of Medicine, Seattle, Washington Abstract Actinic keratosis (AK), the initial lesion in a disease continuum that may progress to squamous cell carcinoma, often begins with ultraviolet B light-induced photo damage and increases in prevalence with age. Topical 5-fluorouracil (5-FU) for the [...]
Continue Reading